News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,159 Results
Type
Article (39998)
Company Profile (271)
Press Release (659890)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (205047)
Career Advice (2020)
Deals (35526)
Drug Delivery (97)
Drug Development (81223)
Employer Resources (172)
FDA (16196)
Job Trends (14906)
News (346380)
Policy (32630)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2571)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49746)
ALS (86)
Alzheimer's disease (1373)
Antibody-drug conjugate (ADC) (115)
Approvals (16196)
Artificial intelligence (241)
Autoimmune disease (21)
Automation (15)
Bankruptcy (362)
Best Places to Work (11658)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (190)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (263)
Cancer (2085)
Cardiovascular disease (166)
Career advice (1686)
Career pathing (29)
CAR-T (144)
Cell therapy (405)
Cervical cancer (19)
Clinical research (65958)
Collaboration (800)
Compensation (505)
Complete response letters (19)
COVID-19 (2598)
CRISPR (38)
C-suite (224)
Cystic fibrosis (100)
Data (2048)
Decentralized trials (2)
Denatured (19)
Depression (39)
Diabetes (257)
Diagnostics (6369)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86462)
Editorial (34)
Employer branding (21)
Employer resources (146)
Events (112392)
Executive appointments (698)
FDA (17378)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (723)
Gene editing (102)
Generative AI (19)
Gene therapy (284)
GLP-1 (701)
Government (4416)
Grass and pollen (4)
Guidances (51)
Healthcare (18831)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (113)
Indications (26)
Infectious disease (2739)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16527)
IRA (42)
Job creations (3663)
Job search strategy (1434)
Kidney cancer (9)
Labor market (36)
Layoffs (465)
Leadership (16)
Legal (7940)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (281)
MASH (62)
Medical device (13352)
Medtech (13357)
Mergers & acquisitions (19513)
Metabolic disorders (657)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (24)
Neuroscience (1881)
NextGen: Class of 2025 (6548)
Non-profit (4487)
Northern California (2534)
Now hiring (38)
Obesity (353)
Opinion (207)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (221)
Patient recruitment (99)
Peanut (46)
People (57535)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20563)
Phase II (29049)
Phase III (21638)
Pipeline (1115)
Policy (130)
Postmarket research (2564)
Preclinical (8706)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (370)
Real estate (5952)
Recruiting (65)
Regulatory (22264)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (127)
Series B (81)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2190)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3625)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (23)
The Weekly (29)
United States (22041)
Vaccines (667)
Venture capitalists (39)
Weight loss (230)
Women's health (34)
Worklife (15)
Date
Today (106)
Last 7 days (495)
Last 30 days (2501)
Last 365 days (33119)
2025 (9201)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37959)
Australia (6224)
California (5795)
Canada (1938)
China (489)
Colorado (253)
Connecticut (262)
Delaware (134)
Europe (81519)
Florida (859)
Georgia (202)
Idaho (58)
Illinois (514)
India (26)
Indiana (300)
Iowa (9)
Japan (148)
Kansas (103)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (857)
Massachusetts (4343)
Michigan (215)
Minnesota (378)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1659)
New Mexico (28)
New York (1649)
North Carolina (936)
North Dakota (7)
Northern California (2534)
Ohio (196)
Oklahoma (14)
Oregon (34)
Pennsylvania (1303)
Puerto Rico (11)
Rhode Island (30)
South America (1099)
South Carolina (19)
South Dakota (1)
Southern California (2190)
Tennessee (99)
Texas (864)
Utah (171)
Virginia (136)
Washington D.C. (60)
Washington State (533)
West Virginia (3)
Wisconsin (51)
700,159 Results for "akoya biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
March 4, 2025
·
11 min read
Press Releases
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
April 2, 2025
·
4 min read
Press Releases
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
January 28, 2025
·
5 min read
Business
Akoya Biosciences Reports First Quarter 2024 Financial Results
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the first quarter ending March 31, 2024.
May 13, 2024
·
11 min read
Press Releases
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
March 17, 2025
·
15 min read
Press Releases
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
February 5, 2025
·
5 min read
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Genetown
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Akoya Biosciences, Inc., The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma patients, announced an exclusive agreement under which the parties will develop market opportunities for combining Akoya’s PhenoImager HT platform and NeraCare’s Immunoprint assay for patient stratification and therapy selection in early-stage melanoma patients.
May 9, 2024
·
5 min read
Business
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
Akoya Biosciences, Inc., The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler®-Fusion and the PhenoImager® HT platforms.
May 6, 2024
·
4 min read
Press Releases
Akoya Biosciences Reports Third Quarter 2024 Financial Results
November 14, 2024
·
12 min read
1 of 70,016
Next
